RAD21 overexpression is frequently observed in BRCA-X Prostate Cancers

RAD21 overexpression is frequently observed in BRCA-X Prostate Cancers

Bibliographic Details
Main Authors:	Deb S, Huiling X, Thorne H, Willems-Jones A, Clouston D, Bolton D, Ramsay R, Fox SB
Format:	Article
Language:	English
Published:	BMC 2012-04-01
Series:	Hereditary Cancer in Clinical Practice
Online Access:	http://www.hccpjournal.com/content/10/S2/A59

Similar Items

Founder mutations in <it>BRCA1/2 </it>are not frequent in Canadian Ashkenazi Jewish men with prostate cancer
by: Kotar Kimberley, et al.
Published: (2003-08-01)

Structural and biochemical analyses of BRCA2 and RAD51 interactions
by: Lo, Thomas Tzan Hong
Published: (2004)

Cohesin Rad21 Mediates Loss of Heterozygosity and Is Upregulated via Wnt Promoting Transcriptional Dysregulation in Gastrointestinal Tumors
by: Huiling Xu, et al.
Published: (2014-12-01)

Control of the RAD51 recombinase by the BRC repeat motifs in the breast cancer susceptibility protein BRCA2
by: Bates, D. L.
Published: (2006)

Use of Radiomics to Improve Diagnostic Performance of PI-RADS v2.1 in Prostate Cancer
by: Mou Li, et al.
Published: (2021-02-01)

Value of an online PI-RADS v2.1 score calculator for assessment of prostate MRI
by: Borna K. Barth, et al.
Published: (2021-01-01)

Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories
by: Renea A. Taylor, et al.
Published: (2017-01-01)

Rad21-cohesin haploinsufficiency impedes DNA repair and enhances gastrointestinal radiosensitivity in mice.
by: Huiling Xu, et al.
Published: (2010-01-01)

Prostate screening uptake in Australian <it>BRCA1 </it>and <it>BRCA2 </it>carriers
by: McKinley Joanne M, et al.
Published: (2007-09-01)

The epistatic relationship between BRCA2 and the other RAD51 mediators in homologous recombination.
by: Yong Qing, et al.
Published: (2011-07-01)

Role of the BRCA2 breast cancer susceptibility protein in control of RAD51 recombinase
by: Yu, David Sung-wen
Published: (2003)

In prostatic transition zone lesions (PI-RADS v2.1): which subgroup should be biopsied?
by: Jihae An, et al.
Published: (2021-08-01)

Correction: Rad21-Cohesin Haploinsufficiency Impedes DNA Repair and Enhances Gastrointestinal Radiosensitivity in Mice
by: Huiling Xu, et al.
Published: (2010-01-01)

Simultaneous Targeting of PARP1 and RAD52 Triggers Dual Synthetic Lethality in BRCA-Deficient Tumor Cells
by: Katherine Sullivan-Reed, et al.
Published: (2018-06-01)

Prostate cancer and targeted screening in BRCA1 and BRCA2 Mutation carriers
by: Mitra, Anita
Published: (2009)

Reduction of BRCA1 Protein Expression in Japanese Sporadic Breast Carcinomas and its Frequent Loss in BRCA1-Associated Caces.
by: Yoshikawa, Kiyotsugu
Published: (2014)

HIF-1α overexpression in ductal carcinoma in situ of the breast in BRCA1 and BRCA2 mutation carriers.
by: Petra van der Groep, et al.
Published: (2013-01-01)

Prostate mpMRI and MRI-Targeted Biopsy: State-of-the-art Protocol + PI-RADS v2.1
by: Pieter De Visschere, et al.
Published: (2019-11-01)

The BRCA2-MEILB2-BRME1 complex governs meiotic recombination and impairs the mitotic BRCA2-RAD51 function in cancer cells
by: Jingjing Zhang, et al.
Published: (2020-04-01)

BRCA1-IRIS overexpression promotes formation of aggressive breast cancers.
by: Yoshiko Shimizu, et al.
Published: (2012-01-01)

Modification of BRCA1-associated breast cancer risk by HMMR overexpression
by: Baiges, A., et al.
Published: (2022)

Modification of BRCA1-associated breast cancer risk by HMMR overexpression
by: Baiges, A., et al.
Published: (2022)

Association of Rad51 polymorphism with DNA repair in BRCA1 mutation carriers and sporadic breast cancer risk
by: Nie Jing, et al.
Published: (2011-06-01)

Incidental prostate cancer in transurethral resection of prostate specimens in men aged up to 65 years
by: Marlon Perera, et al.
Published: (2016-03-01)

Identification of Novel BRCA1 and RAD50 Mutations Associated With Breast Cancer Predisposition in Tunisian Patients
by: Najah Mighri, et al.
Published: (2020-11-01)

RAD52 S346X variant reduces breast cancer risk in BRCA2 mutation carriers
by: Kajal Biswas, et al.
Published: (2020-06-01)

Rad51 and BRCA2--New molecular targets for sensitizing glioma cells to alkylating anticancer drugs.
by: Steve Quiros, et al.
Published: (2011-01-01)

Identification of a RAD52 Inhibitor Inducing Synthetic Lethality in BRCA2-Deficient Cancer Cells
by: Qianye Yang, et al.
Published: (2021-04-01)

Alternative Functional rad21 Paralogs in Fusarium oxysporum
by: Manish Pareek, et al.
Published: (2019-06-01)

Claudin-7 is frequently overexpressed in ovarian cancer and promotes invasion.
by: Neetu Dahiya, et al.
Published: (2011-01-01)

Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs
by: Jean-Fran&#231;ois Emile, et al.
Published: (2008-01-01)

Prognostic Value of BRCA1 and BRCA2 Gene Mutations in Prostate Cancer: a Literature Review
by: M. V. Loginova, et al.
Published: (2021-05-01)

Mutations in BRCA2 and taxane resistance in prostate cancer
by: Cathleen Nientiedt, et al.
Published: (2017-07-01)

BRCA Mutations in Prostate Cancer: Prognostic and Predictive Implications
by: Carlo Messina, et al.
Published: (2020-01-01)

BRCA Germline Mutations in Prostate Cancer: The Future Is Tailored
by: Felice Crocetto, et al.
Published: (2021-05-01)

BRCA2 and Other DDR Genes in Prostate Cancer
by: Paz Nombela, et al.
Published: (2019-03-01)

Cyclin B1 stability is increased by interaction with BRCA1, and its overexpression suppresses the progression of BRCA1-associated mammary tumors
by: Eun Kyung Choi, et al.
Published: (2018-10-01)

Correlation between Intraprostatic PSMA Uptake and MRI PI-RADS of [<sup>68</sup>Ga]Ga-PSMA-11 PET/MRI in Patients with Prostate Cancer: Comparison of PI-RADS Version 2.0 and PI-RADS Version 2.1
by: Jing Zhao, et al.
Published: (2020-11-01)

EUROPSKI SOCIJALNI RAD: IZRADA EKSPERTIZE ZA 21. STOLJEĆE
by: Gabi Čačinović Vogrinčić
Published: (2001-12-01)

The role of Rad21 and its cleavage products in mammary gland
by: Ching-Ying Huang, et al.
Published: (2006)